Double Blind, Double-dummy, Five Parallel Groups, Randomized, Exploratory Clinical Trial to Compare the Efficacy of Single Dose of Levocetirizine 2.5 mg Oral Drops (5 mg/mL), Levocetirizine 5 mg Oral Tablets, Cetirizine 5 mg Oral Drops (10 mg/mL) and Cetirizine 10 mg Oral Tablets to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Ragweed Sensitive Subjects Exposed to Ragweed Pollen in an Environmental Exposure Unit (EEU)
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2018
At a glance
- Drugs Levocetirizine (Primary) ; Cetirizine
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors UCB
- 06 Jun 2007 Status change from in progress to completed.
- 30 Sep 2006 New trial record.